Globally, these results support the potential interest of NRP1 as a prognostic biomarker not only in predicting OS but also in other survival-associated parameters and drug response in patients with advanced CRC or liver cancer, which highlights the interesting role of NRP1 as a therapeutic target. Here, NRP1 is linked to colorectal carcinoma.